Stock info - 9 Meters Biopharma, Inc. Gastrointestinal platform company

Home
About
Pipeline
Investors
Contact us

Home
About
Pipeline
Investors
Contact us

9 Meters Stock Information

Email Alerts Print Page

Data may be delayed up to 15 minutes

9 Meters Biopharma, Inc.

9 Meters Biopharma, Inc. (Nasdaq: NMTR) is a rare and unmet needs focused GI company. The Company is advancing drug candidates for short bowel syndrome and celiac disease. 9 Meters is led by a strong management team with a history of bringing novel therapeutics to market, and the Company owns all global rights to their products, which are backed by more than 150 patents worldwide.

Latest News

Innovate Biopharmaceuticals Announces Full Year 2019 Financial Results And Strategic And Operational Updates
9 Meters Merger Timeline Affirmed
DDW 2020 Abstracts Accepted
Shareholder Approval Complete to Create 9 Meters Biopharma, Inc.
Innovate and RDD Announce 9 Meters

Latest Press Releases

8480 Honeycutt Road, Suite 120
Raleigh, NC 27615

Tel: +1 (919) 275-1933
Mail: info@9meters.com

Twitter
LinkedIn

© Copyright 2020 | 9 Meters Biopharma Inc. All Rights Reserved | Privacy Policy | Cookies Policy